Trials / Unknown
UnknownNCT04804969
MyoVista wavECG Clinical Validation Study Versus Low e' on Echocardiogram
MyoVista wavECG Clinical Validation Study
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 575 (actual)
- Sponsor
- Heart Test Laboratories, Inc. · Industry
- Sex
- All
- Age
- 22 Years
- Healthy volunteers
- Not accepted
Summary
Clinical validation study of the MyoVista wavECG.
Detailed description
This is a multi-center, non-interventional, single arm clinical study of the MyoVista wavECG for the detection of LV relaxation abnormalities. Study subjects will be drawn from patients who are at-risk for cardiac disease and who have been referred for 2D transthoracic echocardiogram. The study will be conducted at a minimum of three investigational sites within the United States.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | MyoVista wavECG Test | The MyoVista wavECG is a standard 12-Lead high-performance, multi-channel resting interpretive electrocardiograph providing both a Glasgow Interpretive Analysis and unique MyoVista wavECG Information. |
Timeline
- Start date
- 2021-05-10
- Primary completion
- 2023-11-30
- Completion
- 2023-11-30
- First posted
- 2021-03-18
- Last updated
- 2023-09-21
Locations
5 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04804969. Inclusion in this directory is not an endorsement.